2026 Forecast: Trends Shaping the Future of Diagnostics
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:
- JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year’s conference.
- Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.
- Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics.
Note: Information in this post was accurate at the time of its posting.
Resources
- Transforming laboratory medicine through AI: From promise to practice
- "Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025
- "Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics
Pas encore de commentaire